Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,470.00
(
-1.06%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,702.00
(
0.26%
)
News Focus
News Focus

Replies to post #8824 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #8824 on Momenta Pharmaceuticals, Inc. (MNTA)
icon url

DewDiligence

03/31/12 8:58 PM

#8826 RE: tony111 #8824

People should scratch M402 off since that program is clearly in limbo…

The M402 program is certainly progressing more slowly than originally anticipated, but I don’t equate this with the program’s being in limbo or having zero value.
icon url

DewDiligence

05/03/12 9:53 AM

#8918 RE: tony111 #8824

People should scratch M402 off since that program is clearly in limbo…

Not anymore—according to today’s PR (#msg-75150121), M402 has started a phase-1/2 trial in pancreatic cancer.